A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- Grant Writing Mini Course – Registration Deadline Today!
- New Jersey coasts, lined with toxic facilities, don’t fare well in two new studies.
- Translational Science Competency-Based Assessment Pilot Test Sign Up
- As few as 2 cigarettes per day linked to 50% increased risk of heart disease: Study
- What You Need to Know About ‘Ozempic Face,’ According to Doctors.
Categories
- Community (2,404)
- Covid (993)
- CTO Events (6)
- News (3,046)
- Pilots (21)